Refresh

Sharon Bio-Medicine Ltd. - Research Center

532908 SHARONBIO Group (Z) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 22 Mar ' 20 Mar ' 18 Mar ' 17 Mar ' 16
Income

Operating income

188.39 171.22 128.46 138.81 253.45
Expenses

Material consumed

95.24 84.26 64.75 237.40 332.25

Manufacturing expenses

- - - - 6.83

Personnel expenses

30.46 29.20 22.63 21.29 16.55

Selling expenses

- - - - -

Adminstrative expenses

36.49 31.36 36.89 45.33 31.67

Expenses capitalised

- - - - -

Cost of sales

162.19 144.82 124.26 304.01 387.29

Operating profit

26.20 26.40 4.19 -165.21 -133.84

Other recurring income

2.81 1.79 2.11 19.85 1.95

Adjusted PBDIT

29.01 28.18 6.30 -145.35 -131.89

Financial expenses

0.11 0.22 - 29.87 70.98

Depreciation

11.23 11.06 10.67 16.12 15.01

Other write offs

- - - - -

Adjusted PBT

17.67 16.91 -4.37 -191.34 -217.89

Tax charges

- - - 2.34 9.97

Adjusted PAT

- - - -193.69 -227.85

Non recurring items

- - -96.93 -154.18 -71.35

Other non cash adjustments

- - - - -

Reported net profit

17.67 16.91 -101.30 -347.86 -299.20

Earnigs before appropriation

17.67 16.91 -101.30 -347.86 -307.42

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

17.67 16.91 -101.30 -347.86 -307.42
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com